Dilip Kumar Dubey

About

M.D. (Internal Medicine, Safdarjang Hospital, New Delhi)
D.M. Pulmonary Medicine, Critical Care and sleep medicine (AIIMS, New Delhi)
Fellowship in Infectious Disease
Fellowship in ECMO
CCIDC (ISHAM)

Employment

• Medanta Hospital Director and Head
  2021 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Contextualizing On-Therapy Resistance Development With Novel Antibiotics: Interplay Between Timing of Therapy Initiation and Critical Illness-Linked Pharmacokinetic/Pharmacodynamic Unpredictability.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 DOI: 10.1093/cid/ciag010
  +Save
• A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp.
  Antimicrobial agents and chemotherapy 2025 DOI: 10.1128/aac.01627-24
  +Save
• From Desperation to Digital Miracle: The Life-Saving Impact of Digital-ICU Technology on an Adolescent’s Journey – A Case Report
  Digital Medicine and Healthcare Technology 2024 DOI: 10.5772/dmht.20240018
  +Save
• Antimicrobial susceptibility pattern of newer beta lactam-beta lactamase inhibitor agents on the carbapenem resistant and sensitive strains of Enterobacterales and Pseudomonas aeruginosa
  IP International Journal of Medical Microbiology and Tropical Diseases 2024 DOI: 10.18231/j.ijmmtd.2024.021
  +Save
• Efficacy and Safety of Oral and IV Levonadifloxacin Therapy in Management of Bacterial Infections: Findings of a Prospective, Observational, Multi-center, Post-marketing Surveillance Study
  Cureus 2024 DOI: 10.7759/cureus.55178
  +Save
• Treatment challenges in the management of difficult-to-treat gram-positive infections: A consensus view apropos therapeutic role of novel anti-MRSA antibiotics, levonadifloxacin (IV) and alalevonadifloxacin (oral)
  Indian Journal of Medical Microbiology 2024 DOI: 10.1016/j.ijmmb.2024.100528
  +Save
• Methylene blue as adjunctive therapy in septic shock: correct drug diluent derives optimal efficacy.
  Critical care (London, England) 2023 DOI: 10.1186/s13054-023-04615-2
  +Save
• CASE REPORT OF SALMONELLA SPLENIC ABSCESS IN ENTERIC FEVER: A RARE PRESENTATION
  WORLD JOURNAL OF PHARMACEUTICAL RESEARCH 2023
  +Save
• A case series of melioidosis: An underdiagnosed infection
  IDCases 2023 DOI: 10.1016/j.idcr.2023.e01685
  +Save
• Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis …
  Annals of Clinical Microbiology and Antimicrobials 2023 DOI: 10.1186/s12941-023-00606-x
  +Save